Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference116 articles.
1. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease;Agnholt;Cytokine,2001
2. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease—a possible target for infliximab treatment;Agnholt;Eur J Gastroenterol Hepatol,2004
3. Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease;Ahn;Inflamm Bowel Dis,2008
4. Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment;Arijs;Am J Gastroenterol,2011
5. Anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab;Armuzzi;Int J Immunopathol Pharmacol,2014
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study;Frontiers in Immunology;2024-07-25
2. Oral administration of RDP58 ameliorated DSS-induced colitis in intestinal microbiota dependent manner;International Immunopharmacology;2024-07
3. G Protein-Coupled Estrogen Receptor-Mediated Anti-Inflammatory and Mucosal Healing Activity of a Trimethylpyridinol Analogue in Inflammatory Bowel Disease;Journal of Medicinal Chemistry;2024-06-19
4. Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases;Pathology - Research and Practice;2023-08
5. Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease;Bioactive Materials;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3